
Sign up to save your podcasts
Or


Dr. Ian Lustbader, Clinical Professor of Medicine at NYU, discusses the latest on Dexamethasone as a treatment for COVID-19 and New York City’s phase two of reopening. Bloomberg Businessweek Editor Joel Weber and Businessweek Editor Silvia Killingsworth walk through stories from the food section in this week's magazine. We get Businessweek Economics with Bloomberg News Economics Reporter Steve Matthews. He talks about his interview with Atlanta Fed President Raphael Bostic. Jason Kelly, CEO at Ginkgo Bioworks, walks through enabling large-scale COVID-19 testing. And we Drive to the Close with Kevin Miller, CIO of E-Valuator Funds.
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
376376 ratings
Dr. Ian Lustbader, Clinical Professor of Medicine at NYU, discusses the latest on Dexamethasone as a treatment for COVID-19 and New York City’s phase two of reopening. Bloomberg Businessweek Editor Joel Weber and Businessweek Editor Silvia Killingsworth walk through stories from the food section in this week's magazine. We get Businessweek Economics with Bloomberg News Economics Reporter Steve Matthews. He talks about his interview with Atlanta Fed President Raphael Bostic. Jason Kelly, CEO at Ginkgo Bioworks, walks through enabling large-scale COVID-19 testing. And we Drive to the Close with Kevin Miller, CIO of E-Valuator Funds.
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.

1,720 Listeners

970 Listeners

404 Listeners

1,170 Listeners

2,201 Listeners

969 Listeners

675 Listeners

198 Listeners

1,038 Listeners

1,302 Listeners

62 Listeners

30 Listeners

59 Listeners

5 Listeners

58 Listeners

233 Listeners

234 Listeners

63 Listeners

85 Listeners

80 Listeners

76 Listeners

86 Listeners

403 Listeners

8 Listeners

18 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners

22 Listeners